AIM Delisting On 22 November 2021, Amryt Pharma plc (the “Company” or “Amryt”) announced its intention to cancel the admission of its ordinary shares of nominal value £0.06 each (the “Ordinary Shares”) to trading on AIM (the “AIM Delisting”) with effect from 7:00 a.m. on 11 January 2022. The announcement can be found here. The shareholder circular can be found here. Expected timetable for the AIM Delisting 22 November 2021 Date of announcement and dispatch of the Circular and enclosed documents 9 December 2021 at 1.00 p.m. Last date for receipt by Link Group from certificated shareholders of duly completed block transfer participation request forms and original share certificates 7 January 2022 Expected date of issuance of ADSs to block transfer participants 7 January 2022 Expected date of posting of ADS confirmations to shareholders by Citibank 10 January 2022 at 3:00 p.m. Last date for receipt by Citibank from CREST holders of duly completed issuance forms 10 January 2022 Last day of dealings in the Ordinary Shares on AIM 11 January 2022 at 7.00 a.m. Cancellation of admission to trading on AIM of the Ordinary Shares FAQs 1. WHAT IS THE RELATIONSHIP BETWEEN THE COMPANY’S ORDINARY SHARES AND ADSs? Each ADS is a tradeable security representing five (5) of the Company’s Ordinary Shares. The Company’s ADSs are listed on Nasdaq under the ticker symbol: AMYT. The value of each ADS is denominated in US Dollars. 2. DO I NEED TO SELL MY AIM-QUOTED ORDINARY SHARES OR MUST I DEPOSIT THEM FOR DELIVERY OF NASDAQ-LISTED ADSs? 3. I DO NOT HAVE A BROKER – DO I REALLY NEED ONE? 4. I CURRENTLY HOLD MY ORDINARY SHARES IN THE FORM OF A PAPER CERTIFICATE HOW DOES THE AIM DELISTING AFFECT ME? 5. I HOLD MY SHARES IN CERTIFICATED FORM AND I WANT TO DEPOSIT MY ORDINARY SHARES FOR DELIVERY OF ADSs PRIOR TO THE AIM DELISTING BUT DO NOT WANT TO ENGAGE A BROKER AT THIS TIME – HOW DO I DO THIS? 6. I HAVE ALREADY INITIATED THE DEMATERIALISATION OF MY UK SHARE CERTIFICATE INTO CREST IN ORDER TO DEPOSIT MY ORDINARY SHARES FOR DELIVERY OF ADSs – WHAT SHOULD I DO? 7. I CURRENTLY HOLD MY ORDINARY SHARES IN UNCERTFICATED/ELECTRONIC FORM IN CREST – HOW DOES THE AIM DELISTING AFFECT ME? 8. MY BROKER CURRENTLY HOLDS MY ORDINARY SHARES WITHIN A CREST NOMINEE ACCOUNT – HOW DO I DEPOSIT MY SHARES FOR DELIVERY OF ADSs? 9. HOW DOES THE PRICE OF NASDAQ-LISTED ADSs COMPARE TO THE PRICE OF ORDINARY SHARES ON AIM? 10. CAN I CONTINUE TO HOLD ORDINARY SHARES AFTER THE AIM DELISTING? 11. I ALREADY HOLD ADSs – AM I AFFECTED BY THE AIM DELISTING? 12. HOW DO I BUY AND SELL NASDAQ LISTED ADSs? 13. IS THERE A COST TO DEPOSIT MY ORDINARY SHARES AND HOLD MY AMRYT INVESTMENT IN THE FORM OF ADSs? 14. HOW WILL THE AIM DELISTING AFFECT THE TAX TREATMENT OF AMRYT’S ORDINARY SHARES? 15. WILL THE AIM DELISTING AFFECT MY RIGHTS AS A SHAREHOLDER? 16. I CURRENTLY HOLD MY ORDINARY SHARES IN AN ISA – CAN I CONTINUE TO DO SO? 17. I CURRENTLY HOLD MY ORDINARY SHARES IN A SELF-INVESTED PERSONAL PENSION “SIPP” – CAN I CONTINUE TO DO SO? 18. I HAVE LOST MY ORIGINAL ORDINARY SHARE CERTIFICATE – HOW DO I GET ANOTHER ONE IN ORDER TO PROGRESS THE DEPOSIT OF MY ORDINARY SHARES FOR DELIVERY OF ADSs? 19. I HAVE FURTHER QUESTIONS THAT ARE NOT DEALT WITH SUFFICIENTLY HERE – WHERE CAN I FIND FURTHER INFORMATION? 20. WHAT IF I AM AN “AFFILIATE” UNDER U.S. SECURITIES LAWS (I.E., A DIRECTOR, EXECUTIVE OFFICER OR BENEFICIAL OWNER OF 10 PER CENT. OR MORE OF THE OUTSTANDING EQUITY OF THE COMPANY)? 21. WHY ISN’T THERE A SHAREHOLDER VOTE TO APPROVE THE DELISTING? Appendix A Appendix B We transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those in greatest need. Privacy policy | Terms and Conditions Cookie policy | Fraud warning Accessibility | Sitemap Website Last updated: 04/08/2021 | Copyright © 2021 Amryt Pharma plc We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. Cookie Settings Accept All